Cargando…
The Lake Victoria island intervention study on worms and allergy-related diseases (LaVIISWA): study protocol for a randomised controlled trial
BACKGROUND: The Hygiene Hypothesis proposes that infection exposure protects against inflammatory conditions. Helminths possess allergen-like molecules and may specifically modulate allergy-related immunological pathways to inhibit responses which protect against them. Mass drug administration is re...
Autores principales: | Nampijja, Margaret, Webb, Emily L, Kaweesa, James, Kizindo, Robert, Namutebi, Milly, Nakazibwe, Esther, Oduru, Gloria, Kabuubi, Prossy, Kabagenyi, Joyce, Kizito, Dennison, Muhangi, Lawrence, Akello, Mirriam, Verweij, Jaco J, Nerima, Barbara, Tukahebwa, Edridah, Elliott, Alison M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4413531/ https://www.ncbi.nlm.nih.gov/pubmed/25902705 http://dx.doi.org/10.1186/s13063-015-0702-5 |
Ejemplares similares
-
The Impact of Intensive Versus Standard Anthelminthic Treatment on Allergy-related Outcomes, Helminth Infection Intensity, and Helminth-related Morbidity in Lake Victoria Fishing Communities, Uganda: Results From the LaVIISWA Cluster-randomized Trial
por: Sanya, Richard E, et al.
Publicado: (2019) -
Anthelminthic treatment receipt and its predictors in Lake Victoria fishing communities, Uganda: Intervention coverage results from the LaVIISWA cluster randomised trial
por: Akurut, Hellen, et al.
Publicado: (2020) -
Schistosoma mansoni and HIV infection in a Ugandan population with high HIV and helminth prevalence
por: Sanya, Richard E., et al.
Publicado: (2015) -
Helminths are positively associated with atopy and wheeze in Ugandan fishing communities: results from a cross‐sectional survey
por: Webb, E. L., et al.
Publicado: (2016) -
Lessons from the first clinical trial of a non-licensed vaccine among Ugandan adolescents: a phase II field trial of the tuberculosis candidate vaccine, MVA85A
por: Wajja, Anne, et al.
Publicado: (2018)